Developer of sustainable cell-free enzyme technology pursuing uses that include active ingredients for nutraceuticals and pharmaceuticals, CEO Michael Heltzen tell GEN Edge
GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
0:12
GEN Edge: What’s in a Name - Out with Invizyne, In with eXoZymes
On September 16 this year, our VP of Business Development, Zachary Karl, PhD, was part of a panel...
